- Home
- A-Z Publications
- Current Pharmaceutical Biotechnology
- Previous Issues
- Volume 24, Issue 3, 2023
Current Pharmaceutical Biotechnology - Volume 24, Issue 3, 2023
Volume 24, Issue 3, 2023
-
-
Methods Applied to the Diagnosis of Cattle Trypanosoma vivax Infection: An Overview of the Current State of the Art
Bovine trypanosomiasis caused by Trypanosoma vivax is a relevant disease in domestic ungulates in Latin America, causing different types of livestock losses, particularly in African and South American countries, leading to loss of millions of dollars/year related to dairy and meat production. In addition, T. vivax trypanosomiasis requires intensive veterinary care. While vector control is a feasible measure to manag Read More
-
-
-
Immunoliposomes: A Targeted Drug Delivery System for Cancer Therapeutics and Vaccination
Authors: Reena Gupta, Jitendra Gupta and Abhishek PathakCancer has become one of the world's most lethal and life-threatening disorders, resulting in many deaths. Drug targeting and managing drug delivery are concepts that are implemented to increase a drug's therapeutic index by enhancing its specificity to particular cells, tissues, or organs and reducing its action and harmful side effects. Liposomes have proven to be one of the most innovative drug delivery systems in medi Read More
-
-
-
Factors and Mechanisms Affecting the Secretion of Recombinant Protein in CHO Cells
Authors: Yong-Xiao Yang, Qin Li, Wei-Dong Li, Tian-Yun Wang and Hui-Gen FengThe market demand for recombinant therapeutic proteins (RTPs) has promoted the development of various protein expression host and bioprocessing technologies. Since mammalian cells have the unique advantage of being able to direct the correct folding of proteins and provide post-translational processing such as complex glycosylation, the RTPs produced by them currently account for approximately 80% of the Read More
-
-
-
COVID-19-associated Coagulopathy: Role of Vitamins D and K
Authors: Bruk Getachew, Harold E. Landis, Kebreten F. Manaye and Yousef TizabiRecent reports show coagulopathy as a potential complication and poorer outcome of coronavirus disease 2019 (COVID-19), especially in those with comorbid conditions such as diabetes and hypertension as thrombosis could result in stroke and heart attacks. Indeed, cardiovascular complications in COVID-19 account for 40% of mortality. Although there is no standard treatment protocol or guidelines for COVID-19, it Read More
-
-
-
Overview of Advancement in Biosensing Technology, Including its Applications in Healthcare
Authors: Sakshi Mishra and Rohitas DeshmukhClinical analysis necessitates using rapid and dependable diagnostic methodologies and approaches. Biomarkers may be an appropriate choice to fulfill this objective, as they are designed uncomplicated in use, specialized for the desired metabolite, susceptible to ongoing analysis and providing excellent outcomes, relatively affordable in the budget, and easily accessible. Biosensing devices are increasingly extensively utilized for Read More
-
-
-
Research Progress in Elucidating the Mechanisms Underlying Resveratrol Action on Lung Cancer
Authors: Rui Xin, Biao Shen, Zhong-Yan Huang, Ji-Bin Liu, Sha Li, Geng-Xi Jiang, Jie Zhang, Ya-Hong Cao, Da-Zhi Zou, Wen Li, Chun-Guang Li, Yu-Shui Ma and Da FuResveratrol has several functions, including protection of the heart and nervous system and exerts antidiabetic, anti-inflammatory, anti-aging, and antitumor effects. It is reported to impede the occurrence and development of tumors in cancer cell lines, animal models, and clinical studies. In vitro and in vivo experiments show that it exerts preventive or adjuvant therapeutic effects in pancreatic, colorectal, prostate, liver, and Read More
-
-
-
Evaluation of the Efficacy of Lactobacillus acidophilus in the Treatment of Cyclophosphamide-induced Hemorrhagic Cystitis in Wistar Rats
Background: Hemorrhagic cystitis is an inflammatory complication that can be caused by the administration of cyclophosphamide, which is widely used as an antineoplastic agent. In the search for new therapeutic alternatives, probiotics can suppress the inflammatory process and, therefore, can be used to prevent this disease. Objective: Thus, this study aimed to evaluate the effects of using Lactobacillus acidophilus NCFM in t Read More
-
-
-
N-acetyl Cysteine Inhibits Cell Proliferation and Differentiation of LPSInduced MC3T3-E1 Cells Via Regulating Inflammatory Cytokines
Authors: Wangyang Li, Hui Zhang, Junchi Chen, Yujie Tan, Ailing Li and Ling GuoBackground: Peri-implantitis is one of the most common complications in oral implantation and could lead to the loss of the function of bone tissues around implants. Methods: This study used lipopolysaccharide (LPS) as a stimulant for MC3T3-E1 cells and N-acetyl cysteine (NAC) as an inhibitor to inhibit the effect of LPS to investigate the effect of NAC on the expression of bone formation related factors and inflammatory-related fa Read More
-
-
-
In vitro Evaluation of Antioxidant and Antibacterial Activities of Eco-friendly Synthesized Silver Nanoparticles using Quercus robur Bark Extract
Aims: This study reports a simple, cost-effective, and environmentally friendly method to obtain silver nanoparticles (AgNPs) using an aqueous extract of Quercus robur bark. Methods: AgNPs synthesis conditions such as silver nitrate concentration, extract:AgNO3 volume ratio, pH, temperature, and reaction time have been examined. After optimizing the synthesis, the obtained AgNPs were characterized by differen Read More
-
Volumes & issues
-
Volume 26 (2025)
-
Volume 25 (2024)
-
Volume 24 (2023)
-
Volume 23 (2022)
-
Volume 22 (2021)
-
Volume 21 (2020)
-
Volume 20 (2019)
-
Volume 19 (2018)
-
Volume 18 (2017)
-
Volume 17 (2016)
-
Volume 16 (2015)
-
Volume 15 (2014)
-
Volume 14 (2013)
-
Volume 13 (2012)
-
Volume 12 (2011)
-
Volume 11 (2010)
-
Volume 10 (2009)
-
Volume 9 (2008)
-
Volume 8 (2007)
-
Volume 7 (2006)
-
Volume 6 (2005)
-
Volume 5 (2004)
-
Volume 4 (2003)
-
Volume 3 (2002)
-
Volume 2 (2001)
-
Volume 1 (2000)
Most Read This Month
Article
content/journals/cpb
Journal
10
5
false
en
